This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Analysts upgraded MetLife, Brinker, Plexus, West Pharma and Omeros, raising ratings and price targets.
Stocks · News reference
Needham Reiterates Buy on Plexus, Maintains $310 Price Target
Needham analyst David Williams reiterates Plexus (NASDAQ:PLXS) with a Buy and maintains $310 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Keybanc Upgrades Plexus to Overweight, Announces $300 Price Target
Keybanc analyst Steve Barger upgrades Plexus (NASDAQ:PLXS) from Sector Weight to Overweight and announces $300 price target.
Shares of electronic equipment-related companies are trading lower, possibly in reaction to rising oil prices.
Plexus Approved New $100M Buyback Program On August 20
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000785786/000078578626000057/plxs-20260824.htm